View in EDS

Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.

Saved in:
Bibliographic Details
Title: Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.
Authors: Singh SK; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Plieskatt J; PATH's Malaria Vaccine Initiative, Washington, WA, USA., Chourasia BK; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Singh V; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Bengtsson KL; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., van Daalen RC; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Teelen K; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., van de Vegte-Bolmer M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., van Gemert GJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands., Jore MM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands. Matthijs.jore@radboudumc.nl., Theisen M; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark. mth@ssi.dk.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. mth@ssi.dk.
Source: NPJ vaccines [NPJ Vaccines] 2021 Oct 12; Vol. 6 (1), pp. 120. Date of Electronic Publication: 2021 Oct 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34642303
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Singh+SK%22">Singh SK</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Plieskatt+J%22">Plieskatt J</searchLink>; PATH's Malaria Vaccine Initiative, Washington, WA, USA.<br /><searchLink fieldCode="AU" term="%22Chourasia+BK%22">Chourasia BK</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Singh+V%22">Singh V</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Bengtsson+KL%22">Bengtsson KL</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Reimer+JM%22">Reimer JM</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22van+Daalen+RC%22">van Daalen RC</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Teelen+K%22">Teelen K</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Vegte-Bolmer+M%22">van de Vegte-Bolmer M</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Gemert+GJ%22">van Gemert GJ</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Jore+MM%22">Jore MM</searchLink>; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands. Matthijs.jore@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22Theisen+M%22">Theisen M</searchLink>; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark. mth@ssi.dk.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. mth@ssi.dk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2021 Oct 12; Vol. 6 (1), pp. 120. <i>Date of Electronic Publication: </i>2021 Oct 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34642303
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41541-021-00383-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 120
    Titles:
      – TitleFull: Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singh SK
      – PersonEntity:
          Name:
            NameFull: Plieskatt J
      – PersonEntity:
          Name:
            NameFull: Chourasia BK
      – PersonEntity:
          Name:
            NameFull: Singh V
      – PersonEntity:
          Name:
            NameFull: Bengtsson KL
      – PersonEntity:
          Name:
            NameFull: Reimer JM
      – PersonEntity:
          Name:
            NameFull: van Daalen RC
      – PersonEntity:
          Name:
            NameFull: Teelen K
      – PersonEntity:
          Name:
            NameFull: van de Vegte-Bolmer M
      – PersonEntity:
          Name:
            NameFull: van Gemert GJ
      – PersonEntity:
          Name:
            NameFull: Jore MM
      – PersonEntity:
          Name:
            NameFull: Theisen M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 10
              Text: 2021 Oct 12
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2059-0105
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ vaccines
              Type: main
ResultId 1